Lung cancer is one of the most common and serious types of cancer. Around 44,500 people are diagnosed with the condition every year in the UK. Lung cancer is the second most common cancer in the UK after breast cancer and is the commonest cause of cancer-related death. The National Lung Cancer Audit (NLCA) was developed in response to the finding in the late 1990s that outcomes for lung cancer patients in the UK lagged behind those in other westernised countries, and varied considerably between organisations within the UK. The audit began collecting data nationally in 2005, and since then has become an exemplar of national cancer audit. In 2015 the Royal College of Physicians won the tender to run the audit for the next three-to-five years.
The NLCA has previously achieved outstanding levels of NHS participation with data being used to drive improvements in the quality of care for people with lung cancer. The Royal College of Physicians aims to build on this success by delivering a new NLCA that incorporates key advances in the field of lung cancer, diagnosis and treatment, whilst retaining the most successful elements of the previous audit.
Additional information on all HQIP-commissioned projects is available on the NHS Trusts page, which includes the recommendations repository, infographics compendium, 9 month publication schedule, impact report, and National Clinical Audit and Enquiries Directory. For further information about this project, please contact the project team directly using the contact details listed in the ‘Supplier Info’ section above.
Contract update – January 2020
A contract opportunity for the National Lung Cancer Audit (NLCA) was advertised in late 2019. The current contract is held by Royal College of Physicians and expires on 31 March 2020.
The timescale for submission of bids is normally a minimum of 35 calendar days. However, additional time was added to take into account the bank holiday Christmas period and the original deadline (6 January) meant the timescale was 48 calendar days. In addition, a further 7 calendar days were given for organisations to submit bids following a request for an extension to account for the deadline falling soon after new year week (a peak week for annual leave in many organisations). As such, the final deadline of 13 January meant a total timescale of 55 calendar days, the longest timescale for an HQIP invitation to tender in at least the last five years.
We did not receive any tenders for this contract opportunity. The project funders (NHS England and Welsh Government) are deciding the next steps for NLCA. Once funders have decided which course they wish to take, we will work closely with them to implement. We and/or the funders will provide updates when more information is available.
Cancer services in England will still be required to submit their data to the National Cancer Registration & Analysis Service (NCRAS) at Public Health England (PHE). Welsh Government will be communicating directly with cancer services in Wales.
Clinical Outcomes Publication (COP)
Clinical outcomes publications provide quality measures at individual consultant, team and unit levels using national clinical audit and administrative data. This project is one of a number of National Clinical Audits who publish these types of data on their website for patients and the public to view; see the project website link above. For an overview, see HQIP’s clinical outcomes publication webpages.
Data collected on behalf of HQIP by all NCAPOP projects is routinely reported and these reports are available in the ‘Latest resources’ section. The reported data is also placed on the data.gov.uk website. Data is also placed upon MyNHSand NHS Choices.
This audit utilises existing datasets rather than bespoke data collection. For details of how to apply for data that is not in the public domain, please contact the project team directly.
Details of the contracts that HQIP awards are available at: www.gov.uk/contracts-finder.